Net Cash Provided by (Used in) Operating Activities |
38.9M |
USD |
-33.7% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
-47.5M |
USD |
-34.2% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-112M |
USD |
-50.1% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
300M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
60.5M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-51.5M |
USD |
+58.3% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
0 |
USD |
|
Q4 2024 |
FY 2024 |
Payments to Acquire Property, Plant, and Equipment |
1.8M |
USD |
-30.8% |
Q1 2025 |
Q1 2025 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
809M |
USD |
+101% |
Q2 2025 |
Q2 2025 |
Deferred Income Tax Expense (Benefit) |
-16.2M |
USD |
+1.22% |
Q2 2025 |
Q2 2025 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
Current Income Tax Expense (Benefit) |
162M |
USD |
+78% |
Q2 2025 |
Q2 2025 |
Preferred Stock, Shares Authorized |
20M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Unrecognized Tax Benefits |
400K |
USD |
-69.2% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
315M |
USD |
+1.22% |
Q4 2024 |
FY 2024 |
Share-based Payment Arrangement, Expense |
34M |
USD |
+11.1% |
Q2 2025 |
Q2 2025 |
Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |